Paper4188976
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).
Alper CA and 4 others. N Engl J Med, 1970. Cited by 327 papers, by iCite.
Cite this record
ConductScience Library. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). Papers, record 4188976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4188976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement System Proteins | Major topic |
| Immunologic Deficiency Syndromes | Major topic |
| Infections | Major topic |
| Adult | |
| Antibodies | |
| Antibody Formation | |
| Blood Bactericidal Activity | |
| Chemotaxis | |
| Hemagglutination Tests | |
| Hemolysis | |
| Humans | |
| Hypersensitivity, Delayed | |
| Immunoelectrophoresis | |
| In Vitro Techniques | |
| Klinefelter Syndrome | |
| Leukocytes | |
| Male | |
| Phagocytosis | |
| gamma-Globulins |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 327 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41873701 | Increased MAP-1 and lectin complement activation capacity in Klinefelter syndrome. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41873701 | PubMed |
| 40713518 | Complete Complement Factor I (CFI) deficiency: a systematic review of forty-nine patients including three novel cases. | BMC Immunol | 2025 | https://conductscience.org/library/papers/40713518 | PubMed |
| 36408746 | Physiology and pathology of the C3 amplification cycle: A retrospective. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36408746 | PubMed |
| 31121434 | Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. | Curr Opin Immunol | 2019 | https://conductscience.org/library/papers/31121434 | PubMed |
| 25663093 | Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe. | J Clin Immunol | 2015 | https://conductscience.org/library/papers/25663093 | PubMed |
| 25330773 | Structural determinants of host specificity of complement Factor H recruitment by Streptococcus pneumoniae. | Biochem J | 2015 | https://conductscience.org/library/papers/25330773 | PubMed |
| 24161036 | Dense deposit disease and C3 glomerulopathy. | Semin Nephrol | 2013 | https://conductscience.org/library/papers/24161036 | PubMed |
| 22855389 | The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro. | Clin Vaccine Immunol | 2012 | https://conductscience.org/library/papers/22855389 | PubMed |
| 21245150 | Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21245150 | PubMed |
| 18981135 | Species-specific interaction of Streptococcus pneumoniae with human complement factor H. | J Immunol | 2008 | https://conductscience.org/library/papers/18981135 | PubMed |
| 18805611 | Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. | Am J Kidney Dis | 2009 | https://conductscience.org/library/papers/18805611 | PubMed |
| 18215115 | Pathogenesis of thrombotic microangiopathies. | Annu Rev Pathol | 2008 | https://conductscience.org/library/papers/18215115 | PubMed |
| 16412054 | Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family. | Clin Exp Immunol | 2006 | https://conductscience.org/library/papers/16412054 | PubMed |
| 16030389 | Antiinflammatory and immunomodulating properties of fungal metabolites. | Mediators Inflamm | 2005 | https://conductscience.org/library/papers/16030389 | PubMed |
| 15972516 | Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3. | Infect Immun | 2005 | https://conductscience.org/library/papers/15972516 | PubMed |
| 15589313 | Exceptional matters. | Lancet | 2004 | https://conductscience.org/library/papers/15589313 | PubMed |
| 12477926 | The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12477926 | PubMed |
| 11107496 | Complement deficiency. | Clin Rev Allergy Immunol | 2000 | https://conductscience.org/library/papers/11107496 | PubMed |
| 10973451 | Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines. | Clin Diagn Lab Immunol | 2000 | https://conductscience.org/library/papers/10973451 | PubMed |
| 9858525 | A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. | J Exp Med | 1998 | https://conductscience.org/library/papers/9858525 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4188976
GET https://conductscience.org/api/papers/v1/4188976/cited_by?page=2